PAL: The Peer Assisted Lifestyle Intervention

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT03163264
Collaborator
(none)
281
1
2
47.7
5.9

Study Details

Study Description

Brief Summary

The PAL intervention uses a new software tool delivered on tablets to facilitate 5As-based weight management counseling with a health coach and the VA PACT healthcare team to promote goal-setting, behavior change, and weight loss in the primary care (PC) setting. The PAL intervention also includes 10-12 health-coaching calls to the patient over 12 months.

As part of a cluster-randomized controlled study, the investigators will randomize 17 PACT teams at the Brooklyn VA to receive either the PAL Intervention or an Enhanced Usual Care control. The primary aim of the study is to explore differences in feasibility, acceptability, and intermediate, behavioral, and weight loss outcomes at 6 and 12 months of 520 patients recruited from the randomized PACTs.

Objective:
  1. Explore the feasibility and impact of this intervention on intermediate, behavioral, and weight loss outcomes at 6 and 12 months post-intervention when compared to enhanced usual care.
Condition or Disease Intervention/Treatment Phase
  • Behavioral: Peer Assisted Lifestyle
  • Behavioral: Enhanced Usual Care
N/A

Detailed Description

Veterans shoulder a disproportionate burden of obesity and its co-morbidities, including diabetes, hypertension, and hyperlipidemia. Modest weight loss in obese patients through diet and exercise improves health and prevents chronic disease, but primary care providers (PCPs) often fail to adequately counsel patients about their weight due to lack of time and training. Thus, tools and brief interventions are needed to support providers' behavior change counseling. The VA currently offers the MOVE! program to treat overweight and obese patients, but only 9% of eligible patients attend. At the same time, Veterans on average see their PCPs 3.6 times per year, which supports the importance of developing primary care (PC)-based interventions. The United States Preventive Services Task force (USPSTF) recommends the use of the 5As framework (Assess, Advise, Agree, Assist, Arrange) for counseling patients about weight.

Interactive behavior change technologies utilizing expert system software programs are an innovative way to facilitate 5As counseling to promote behavior change in primary care. These programs perform computerized risk, lifestyle, and theory- based, behavioral assessment to provide computer-generated, tailored advice to patients. They also can provide information to healthcare teams. The MOVE!11 software is an expert system program for VA patients referred to MOVE!, but is not currently used in primary care by Patient-Aligned Care Teams (PACT).

Collaborative goal setting can be used to achieve behavior change in this intervention. This construct, a critical component of several behavior change theories and models and corresponding to "agree" in the 5As model, has been widely recommended for health promotion in primary care. The investigators' formative work (MIRB #01333) using key informant interviews with PACT teamlets and MOVE! staff and focus groups with Veterans demonstrated that goal setting is feasible and acceptable to patients and PACT teamlets and provided insight on barriers to goal setting, and ways to facilitate goal-setting conversations.

During the development phase of this project, the investigators developed a primary care-based intervention called MOVE! Toward Your Goals (MTG) to facilitate weight management within primary care and increase adoption of intensive VA programs such as MOVE!. The PAL intervention uses the MTG software tool (that the investigators developed) delivered on tablets to facilitate 5As-based weight management counseling with a health coach and healthcare team to promote goal-setting, behavior change, and weight loss in the primary care setting. The Veteran also receives follow up with 10-12 health coaching calls over 1 year.

As part of a clustered randomized control trial, the investigators will randomize 17 PACT teams to either Enhanced Usual Care or the PAL Intervention, recruiting 520 subjects.

STUDY OBJECTIVES

  • Test the impact of the PAL intervention on weight change and behavioral/clinical outcomes

  • Identify predictors of weight loss in Veterans participating in the intervention group related to goal setting processes and intervention components

  • Determine the impact of the PAL intervention on PACT obesity-related counseling practices and attitudes

Study Design

Study Type:
Interventional
Actual Enrollment :
281 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Testing the Efficacy of a Technology-assisted Intervention to Improve Weight Management of Obese Patients Within Patient Aligned Care Teams at the VA
Actual Study Start Date :
Jan 8, 2018
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: PAL Intervention

Body mass index of =30kg/m2 OR Body mass index of =25 kg/m2 with an obesity associated co-morbidity Receiving Peer Assisted Lifestyle intervention (PAL tool, health coaching at baseline, follow-up health coaching calls, potential support of goals from primary care provider)

Behavioral: Peer Assisted Lifestyle
Patients will use PAL online tool accessing weight management and lifestyle behaviors, and will meet with a health coach regularly to establish SMART goals.
Other Names:
  • PAL arm
  • Active Comparator: Enhanced Usual Care (EUC)

    Body mass index of =30kg/m2 OR Body mass index of =25 kg/m2 with an obesity associated co-morbidity

    Behavioral: Enhanced Usual Care
    Patients will be given information on "healthy living messages" that were created by the VA, and given more information on specific messages they are interested in from the health coaches, but will not receive official coaching. These messages are the current standard of care at the VA for obesity counseling.
    Other Names:
  • EUC arm
  • Outcome Measures

    Primary Outcome Measures

    1. Mean Weight Loss [6 and 12 months]

      Mann-Whitney tests for continuous outcomes (e.g., weight loss)

    2. Difference in achievement of 5% weight loss [12 months]

      Fisher's exact tests for categorical outcomes will be used to compare the two intervention arms at 12 months

    Secondary Outcome Measures

    1. Changes in HB A1C [6 and 12 month]

      Fasting blood tests will be used to determine if patients experience changes in HB A1C level.

    2. Changes in waist circumference [6 and 12 months]

      Will be used to determine whether patients had changes in waist circumference.

    3. Changes in Physical Activity [6 and 12 months]

      Measure duration and intensity using the Paffenbarger questionnaire items and accelerometers. The ActiGraph Link (GT9X) accelerometer, worn on the wrist, will be used to objectively measure PA for 7 days at Baseline, and at 6 and 12 months.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 69 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age 18-69 (this age range represents MOVE! eligibility)

    • BMI of 30kg/m2 or a BMI of 25kg/m2 with obesity-associated condition

    • Under the care of PCP with at least 1 prior visit with the provider in the past 24 months

    • Access to a telephone

    • Able to travel to Brooklyn VA for in-person evaluations at baseline, 6, and 12 months

    Exclusion Criteria:
    • Non-Veterans

    • A documented current history of active psychosis, active bipolar disorder, or other cognitive issues via ICD-10 codes

    • Undergoing insulin-therapy for diabetes

    • Self-reported inability to read at a 5th grade level due to literacy level or vision problems

    • Has attended more than 4 MOVE! sessions in the past year

    • Pregnancy

    • PCP stating that Veteran should not participate

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY New York New York United States 10010

    Sponsors and Collaborators

    • VA Office of Research and Development

    Investigators

    • Principal Investigator: Melanie R. Jay, MD MS, Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    VA Office of Research and Development
    ClinicalTrials.gov Identifier:
    NCT03163264
    Other Study ID Numbers:
    • IIR 15-378
    • 01607
    First Posted:
    May 23, 2017
    Last Update Posted:
    Feb 10, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by VA Office of Research and Development
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 10, 2022